Phase II trial of sorafenib (bay 43-9006) in malignant mesothelioma: CALGB 30307

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Janne, PA; Wang, XF; Krug, LM; Hodgson, L; Vokes, EE; Kindler, HL

Published Date

  • January 1, 2006

Published In

Volume / Issue

  • 17 /

Start / End Page

  • 216 - 217

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 31st Congress of the European-Society-for-Medical-Oncology

Conference Location

  • Istanbul, TURKEY

Conference Start Date

  • September 29, 2006

Conference End Date

  • October 3, 2006